Перспективы лечения больных урогинекологического профиля в условиях пандемии COVID-19 и последующего снятия ограничительных мер

Перспективы лечения больных урогинекологического профиля в условиях пандемии COVID-19 и последующего снятия ограничительных мер

Автор: Гвоздев М.Ю., Шадеркина В.А., Шадеркин И.А., Джураева М.Д., Арефьева О.А.

Журнал: Экспериментальная и клиническая урология @ecuro

Рубрика: Организация урологической помощи

Статья в выпуске: 2, 2020 года.

Бесплатный доступ

Введение. Пандемия новой коронавирусной инфекции COVID-19 заставила мировую медицину полностью изменить стратегию оказания помощи целому ряду пациентов. В данной публикации рассматриваются вопросы оказания специализированной помощи урогинекологическим больным в условиях пандемии новой коронавирусной инфекции, а также перспективы восстановления планового хирургического лечения после снятия карантинных мер. Материалы и методы. Пандемия COVlD-19 привело к существенному ограничению доступности амбулаторной и стационарной медицинской помощи, что явилось хорошим стимулом для более активного использования дистанционных методов ведения и мониторинга больных, в том числе с использованием телемедицинских технологий. Авторы рассмотрели доступные публикации в Pubmed и проанализировали опыт оказанияурогинекологической помощи в условиях COVID-19. Результаты. Послеоперационные онлайн-консультации в подавляющем большинстве случаев хорошо воспринимаются пациентками и оправдывают их ожидания. Лечение неосложненной острой и рецидивирующей мочевой инфекции возможно без визита в стационар. Большинство плановых хирургических вмешательств не требуют выполнения в короткие сроки и вполне могут быть отложены на несколько месяцев. Пациенткам, претендующим на интрадетрузорное введение ботулинического токсина типа А или электростимуляцию большеберцового нерва, может быть предложено медикаментозное лечение. Во всех случаях необходима оценка существующих рисков развития побочных эффектов и рисков инфицирования новой коронавирусной инфекцией COVID-19. Выводы. В условиях изменившегося под влиянием COVID-19 мира, необходима тщательная оценка рисков для урогинекологических пациенток - при проведении очной консультации, при планировании хирургического лечения, в том числе экстренных вмешательств. Недопустимо игнорирование интересов пациенток урогинекологического профиля под предлогом борьбы с эпидемией.

Еще

Коронавирусная инфекция, пандемия, урогинекологические заболевания, pandemiа

Короткий адрес: https://sciup.org/142225670

IDR: 142225670   |   DOI: 10.29188/2222-8543-2020-12-2-24-32

Список литературы Перспективы лечения больных урогинекологического профиля в условиях пандемии COVID-19 и последующего снятия ограничительных мер

  • Smith AC, Thomas E, Snoswell CL, Haydon H, Mehrotra A, Clemensen J, Caffery LJ (2020) Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19). J Telemed Telecare 2020; 26(5):309-313. DOI: 10.1177/1357633X20916567
  • Rogers RG, Swift S. The world is upside down; how coronavirus changes the way we care for our patients. Int Urogynecol J 2020 May;31(5):853-854. DOI: 10.1007/s00192-020-04292-7
  • Schlittenhardt M, Smith SC, Ward-Smith P. Telecontinence care: A novel approach for providers. Urol Nurs 2016;36:217-23.
  • Balzarro M, Rubilotta E, Trabacchin N, Mancini V, Costantini E, Artibani W, et al. A prospective comparative study of the feasibility and reliability of telephone follow-up in female urology: the patient Home Office novel evaluation (PhOnE) study. urology 2020;136:82-7. DOI: 10.1016/j.urology.2019.10.021
  • Barry HC, Hickner J, Ebell MH, Ettenhofer T. A randomized controlled trial of telephone management of suspected urinary tract infections in women. J Fam Tract 2001;50:589-94.
  • Gordon AS, Adamson WC, DeVries AR. Virtual visits for acute, nonurgent care: A claims analysis of episode-level utilization. J Med Internet Res 2017;19:e35.
  • DOI: 10.2196/jmir.6783
  • Jones G, Brennan V, Jacques R, Wood H, Dixon S, Radley S. Evaluating the impact of a "virtual clinic" on patient experience, personal and provider costs of care in urinary incontinence: A randomized controlled trial. PLoS One 2018;13:e0189174.
  • DOI: 10.1371/journal.pone.0189174
  • Mehrotra A, Paone S, Martich GD, Albert SM, Shevchik GJ. A comparison of care at e-visits and physician office visits for sinusitis and urinary tract infection. JAMA Intern Med 2013;173:72-4.
  • DOI: 10.1001/2013.jamainternmed.305
  • Tates K, Antheunis ML, Kanters S, Nieboer TE, Gerritse MB. The effect of screen-to-screen versus face-to-face consultation on doctor-patient communication: an experimental study with simulated patients. J Med Internet Res 2017; 20;19(12):e421.
  • DOI: 10.2196/jmir.8033
  • Thompson JC, Cichowski SB, Rogers RG, Qeadan F, Zambrano J, Wenzl C, et al. Outpatient visits versus telephone interviews for postoperative care: a randomized controlled trial. Int Urogynecol J. 2019;30:1639-46.
  • DOI: 10.1007/s00192-019-03895-z
  • Akbar N, Dobson EL, Keefer M, Munsiff S, Dumyati G. 1082. Hold the phone: antibiotic prescribing practices associated with nonvisit encounters for urinary tract infections (UTIs) in urology clinics. Open Forum Infect Dis. 2019;6:S384. 10. 1093/ofid/ofz360.946.
  • DOI: 10.1093/ofid/ofz360.946
  • Agency for Healthcare Research and Quality Evidence-based Practice Center Program Rapid Review Guidance Document. https://www.ahrq.gov/sites/default/files/wysiwyg/lunding/ contracts/epc-vi/22-rapid_evidence_products_guidance.pdf. Accessed 4 Apr 2020.
  • Centers for Medicare and Medicaid Services (CMS) Medicare Telemedicine Healthcare Provider Fact Sheet. https://www.cms. gov/newsroom/fact-sheets/medicare-telemedicine-health-care- provider-fact-sheet. Accessed 3 Apr 2020.
  • International Urogynecologic Association (IUGA) Your Pelvic Floor Leaflets. https://www.yourpelvicfloor.org/leaflets/. Accessed 5 Apr 2020.
  • American Urogynecologic Association (AUGS) Voices for Pelvic Floor Disorders Fact Sheets and Downloads. https://www. voicesforpfd.org/resources/fact-sheets-and-downloads/. Accessed 5 Apr 2020.
  • National Association for Continence (NAFC) Urinary incontinence Education Learning Library. https://www.nafc.org/ learning-library. Accessed 5 Apr 2020.
  • Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52:e103-20.
  • DOI: 10.1093/cid/ciq257
  • Bent S, Saint S. The optimal use of diagnostic testing in women with acute uncomplicated cystitis. Am JMed. 2002;113(Suppl 1A):20S-8S.
  • DOI: 10.1016/s0002-9343(02)01056-2
  • DeAlleaume L, Tweed EM, Bonacci R. Clinical inquiries. When are empiric antibiotics appropriate for urinary tract infection symptoms? JFam Pract. 2006;55(338):341-2.
  • Ross AM. UTI antimicrobial resistance: tricky decisions ahead? Br J Gen Pract. 2000;50:612-3.
  • Dixon T. Urinary tract infections. Management mayhem? Can Fam Physician. 1993;39:474-9.
  • McQuiston Haslund J, Rosborg Dinesen M, Sternhagen Nielsen AB, Llor C, Bjerrum L. Different recommendations for empiric first-choice antibiotic treatment of uncomplicated urinary tract infections in Europe. Scand J Prim Health Care. 2013;31:235-40.
  • DOI: 10.3109/02813432.2013.844410
  • Mishra B, Srivastava S, Singh K, Pandey A, Agarwal J. Symptom- based diagnosis of urinary tract infection in women: are we over-prescribing antibiotics? Int J Clin Pract. 2012;66:493-8.
  • DOI: 10.1111/j.1742-1241.2012.02906.x
  • Giesen LGM, Cousins G, Dimitrov BD, van de Laar FA, Fahey T. Predicting acute uncomplicated urinary tract infection in women: a systematic review of the diagnostic accuracy of symptoms and signs. BMC Fam Pract. 2010;11:78. 10.1186/ 1471-2296-11-78.
  • DOI: 10.1186/1471-2296-11-78
  • Linsenmeyer K, Strymish J, Gupta K. Two simple rules for improving the accuracy of empiric treatment of multidrug-resistant urinary tract infections. Antimicrob Agents Chemother. 2015;59: 7593-6.
  • DOI: 10.1128/AAC.01638-15
  • MacFadden DR, Ridgway JP, Robicsek A, Elligsen M, Daneman N. Predictive utility of prior positive urine cultures. Clin Infect Dis. 2014;59:1265-71.
  • DOI: 10.1093/cid/ciu588
  • Clark R, Welk B. The ability of prior urinary cultures results to predict future culture results in neurogenic bladder patients. Neurourol Urodyn. 2018;37:2645-50.
  • DOI: 10.1002/nau.23713
  • Vellinga A, Cormican M, Hanahoe B, Murphy AW. Predictive value of antimicrobial susceptibility from previous urinary tract infection in the treatment of reinfection. Br J Gen Pract. 2010;60: 511-3.
  • DOI: 10.3399/bjgp10X514765
  • Tchesnokova V, Riddell K, Scholes D, Johnson JR, Sokurenko EV. The uropathogenic Escherichia coli subclone sequence type 131-H30 is responsible for most antibiotic prescription errors at an urgent care clinic. Clin Infect Dis. 2019;68:781-7.
  • DOI: 10.1093/cid/ciy523
  • McGregor JC, Elman MR, Bearden DT, Smith DH. Sex- and agespecific trends in antibiotic resistance patterns of Escherichia coli urinary isolates from outpatients. BMC Fam Pract. 2013;14:25.
  • DOI: 10.1186/1471-2296-14-25
  • Chiu C-C, Lin T-C, Wu R-X, Yang Y-S, Hsiao P-J, Lee Y, et al. Etiologies of community-onset urinary tract infections requiring hospitalization and antimicrobial susceptibilities of causative microorganisms. J Microbiol Immunol Infect. 2017;50:879-85.
  • DOI: 10.1016/j.jmii.2016.08.008
  • Dokter J, Tennyson LE, Nguyen L, Han E, Sirls LT. The clinical rate of antibiotic change following empiric treatment for suspected urinary tract infections. Int Urol Nephrol. 2020;52:431-6.
  • DOI: 10.1007/s11255-019-02327-7
  • George CE, Norman G, Ramana GV, Mukherjee D, Rao T. Treatment of uncomplicated symptomatic urinary tract infections: resistance patterns and misuse of antibiotics. J Family Med Prim Care. 2015;4:416-21.
  • DOI: 10.4103/2249-4863.161342
  • Leibovici L, Greenshtain S, Cohen O, Wysenbeek AJ. Toward improved empiric management of moderate to severe urinary tract infections. Arch Intern Med. 1992;152:2481-6.
  • Andriole VT. When to do culture in urinary tract infections. Int J Antimicrob Agents. 1999;11:253-5; discussion 261. https://doi. org/.
  • DOI: 10.1016/s0924-8579(99)00025-4
  • Lutters M, Vogt-Ferrier NB (2008) Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women. Cochrane Database Syst Rev CD001535.
  • DOI: 10.1002/14651858.CD001535.pub2
  • Faro S, Fenner DE. Urinary tract infections. Clin Obstet Gynecol. 1998;41:744-54.
  • DOI: 10.1097/00003081-199809000-00030
  • Guneysel O, Onur O, Erdede M, Denizbasi A. Trimethoprim/ sulfamethoxazole resistance in urinary tract infections. JEmerg Med. 2009;36:338-41.
  • DOI: 10.1016/j.jemermed.2007.08.068
  • Johnson L, Sabel A, Burman WJ, Everhart RM, Rome M, MacKenzie TD, et al. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med. 2008;121:876-84.
  • DOI: 10.1016/j.amjmed.2008.04.039
  • Le TP, Miller LG. Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis. Clin Infect Dis. 2001;33:615-21.
  • DOI: 10.1086/322603
  • Knottnerus BJ, Grigoryan L, Geerlings SE, Moll van Charante EP, Verheij TJM, Kessels AGH, et al. Comparative effectiveness of antibiotics for uncomplicated urinary tract infections: network metaanalysis of randomized trials. Fam Pract. 2012;29:659-70.
  • DOI: 10.1093/fampra/cms029
  • Gupta K. Addressing antibiotic resistance. Dis Mon. 2003;49:99-110.
  • DOI: 10.1067/mda.2003.10
  • Nicolle L, Anderson PAM, Conly J, Mainprize T C, Meuser J, Nickel JC, et al. Uncomplicated urinary tract infection in women. Current practice and the effect of antibiotic resistance on empiric treatment. Can Fam Physician. 2006;52:612-8.
  • Cohn EB, Schaeffer AJ. Urinary tract infections in adults. Scientific World Journal. 2004;4 (Suppl 1):76-88.
  • DOI: 10.1100/tsw.2004.50
  • Nicolle LE. Update in adult urinary tract infection. Curr Infect Dis Rep. 2011;13:552-60.
  • DOI: 10.1007/s11908-011-0212-x
  • Bischoff S, Walter T, Gerigk M, Ebert M, Vogelmann R. Empiric antibiotic therapy in urinary tract infection in patients with risk factors for antibiotic resistance in a German emergency department. BMC Infect Dis. 2018;18:56.
  • DOI: 10.1186/s12879-018-2960-9
  • Bader MS, Hawboldt J, Brooks A. Management of complicated urinary tract infections in the era of antimicrobial resistance. Postgrad Med. 2010;122:7-15.
  • DOI: 10.3810/pgm.2010.11.2217
  • Hsueh P-R, Hoban DJ, Carmeli Y, Chen S-Y, Desikan S, Alejandria M, et al. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. J Inf Secu r. 2011;63:114-23.
  • DOI: 10.1016/j.jinf.2011.05.015
  • Naber KG. Which fluoroquinolones are suitable for the treatment of urinary tract infections? Int J Antimicrob Agents. 2001;17:331- 4.
  • Datta R, Advani S, Rink A, Bianco L, Van Ness PH, Quagliarello V, et al. Increased fluoroquinolone-susceptibility and preserved nitrofurantoin-susceptibility among Escherichia coli urine isolates from women long-term care residents: A brief report. Open Access J Gerontol Geriatr Med. 2018.
  • DOI: 10.19080/OAJGGM.2018.04.555636
  • Hanlon JT, Perera S, Drinka PJ, Crnich CJ, Schweon SJ, Klein- Fedyshin M, et al. The IOU consensus recommendations for empirical therapy of cystitis in nursing home residents. J Am Geriatr Soc. 2019;67:539-45.
  • DOI: 10.1111/jgs.15726
  • McCue JD. Rationale for the use of oral fluoroquinolones as empiric treatment of nursing home infections. Arch Fam Med. 1994;3:157-64.
  • Naber KG, Wullt B, Wagenlehner FME. Antibiotic treatment of uncomplicated urinary tract infection in premenopausal women. Int J Antimicrob Agents. 2011;38(Suppl):21-35.
  • DOI: 10.1016/j.ijantimicag.2011.09.003
  • Stapleton A. Urinary tract infections in patients with diabetes. Am J Med. 2002; 113 (Suppl 1A):80S-4S.
  • DOI: 10.1016/s0002-9343(02)01062-8
  • File TM, Tan JS. Urinary tract infections in the elderly. Geriatrics. 1989;44(Suppl A):15-9.
  • Das R, Perrelli E, Towle V, Van Ness PH, Juthani-Mehta M. Antimicrobial susceptibility of bacteria isolated from urine samples obtained from nursing home residents. Infect Control Hosp Epidemiol. 2009;30:1116-9.
  • DOI: 10.1086/647981
  • Wojno KJ, Baunoch D, Luke N, Opel M, Korman H, Kelly C, et al. Multiplex PCR based urinary tract infection (UTI) analysis compared to traditional urine culture in identifying significant pathogens in symptomatic patients. Urology. 2020;136:119-26.
  • DOI: 10.1016/j.urology.2019.10.018
  • Kranjcec B, Papes D, Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014;32:79-84.
  • DOI: 10.1007/s00345-013-1091-6
  • Anger J, Lee U, Ackerman AL, Chou R, Chughtai B, Clemens JQ, et al. Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline. J Urol. 2019;202:282-9.
  • DOI: 10.1097/JU.0000000000000296
  • Miceli A, Ferrnndez-San chez M, Polo-Padillo J, Duern s-Dle z J- L. Is it safe and effective to maintain the vaginal pessary without removing it for 2 consecutive years? Int Urogynecol J. 2020.
  • DOI: 10.1007/s00192-020-04240-5
  • Propst K, Mellen C, O'Sullivan DM, Tulikangas PK. Timing of office-based pessary care: A randomized controlled trial. Obstet Gynecol. 2020;135:100-5. 10.1097/AOG. 0000000000003580.
  • DOI: 10.1097/AOG.0000000000003580
  • Tam M-S, Lee VYT, Yu ELM, Wan RSF, Tang JSM, He JMY, et al. The effect of time interval of vaginal ring pessary replacement for pelvic organ prolapse on complications and patient satisfaction: A randomized controlled trial. Maturitas. 2019;128:29- 35.
  • DOI: 10.1016/j.maturitas.2019.07.002
  • Cheung RYK, Lee JHS, Lee LL, Chung TKH, Chan SSC. Vaginal pessary in women with symptomatic pelvic organ prolapse: A randomized controlled trial. Obstet Gynecol. 2016;128:73-80.
  • DOI: 10.1097/AOG.0000000000001489
  • Thys SD, Hakvoort RA, Asseler J, Milani AL, Vollebregt A, Roovers JP Effect of pessary cleaning and optimal time interval for follow-up: a prospective cohort study. Int Urogynecol J. 2020.
  • DOI: 10.1007/s00192-019-04200-8
  • Chien C-W, Lo T-S, Tseng L-H, Lin Y-H, Hsieh W-C, Lee S-J. Long-term outcomes of self-management Gellhorn pessary for symptomatic pelvic organ prolapse. Female Pelvic Med Reconstr Surg. 2019.
  • DOI: 10.1097/SPV.0000000000000770
  • Lone F, Thakar R, Sultan AH, Karamalis G. A 5-year prospective study of vaginal pessary use for pelvic organ prolapse. Int J Gynaecol Obstet. 2011;114:56-9.
  • DOI: 10.1016/j.ijgo.2011.02.006
  • Ramsay S, Tu LM, Tannenbaum C. Natural history of pessary use in women aged 65 - 74 versus 75 years and older with pelvic organ prolapse: a 12-year study. Int Urogynecol J. 2016;27:1201-7.
  • DOI: 10.1007/s00192-016-2970-3
  • Manchana T. Ring pessary for all pelvic organ prolapse. Arch Gynecol Obstet. 2011;284:391-5.
  • DOI: 10.1007/s00404-010-1675-y
  • Dessie SG, Armstrong K, Modest AM, Hacker MR, Hota LS. Effect of vaginal estrogen on pessary use. Int Urogynecol J. 2016;27:1423-9.
  • DOI: 10.1007/s00192-016-3000-1
  • Deng M, Ding J, Ai F, Zhu L. Successful use of the Gellhorn pessary as a second-line pessary in women with advanced pelvic organ prolapse. Menopause. 2017;24:1277-81.
  • DOI: 10.1097/GME.0000000000000909
  • Sasaki T, Agari T, Date I. Devices and practices for improving the accuracy of deep brain stimulation. No Shinkei Geka. 2018;46: 751-62.
  • DOI: 10.11477/mf.1436203809
  • Kasper S. Editorial issue 4/2019. Int J Psychiatry Clin Pract. 2019;23:237.
  • DOI: 10.1080/13651501.2019.1688484
  • Wu V, Farrell SA, Baskett TF, Flowerdew G. A simplified protocol for pessary management. Obstet Gynecol. 1997;90:990-4.
  • DOI: 10.1016/s0029-7844(97)00481-x
  • Yang J, Han J, Zhu F, Wang Y. Ring and Gellhorn pessaries used in patients with pelvic organ prolapse: a retrospective study of 8 years. Arch Gynecol Obstet. 2018;298:623-9.
  • DOI: 10.1007/s00404-018-4844-z
  • Collins S, Beigi R, Mellen C, O'Sullivan D, Tulikangas P The effect of pessaries on the vaginal microenvironment. Am J Obstet Gynecol. 2015;212:60.e1-6.
  • DOI: 10.1016/j.ajog.2014.07.024
  • de A Coelho SC, Giraldo PC, Florentino JO, de Castro EB, LGO B, CRT J. Can the pessary use modify the vaginal microbiological flora? A cross-sectional study. Rev Bras Ginecol Obstet. 2017;39:169-74.
  • DOI: 10.1055/s-0037-1601437
  • Deng M, Ding J, Ai F, Zhu L. Clinical use of ring with support pessary for advanced pelvic organ prolapse and predictors of its short-term successful use. Menopause. 2017;24:954-8.
  • DOI: 10.1097/GME.0000000000000859
  • Balk EM, Rofeberg VN, Adam GP, Kimmel HJ, Trikalinos TA, Jeppson PC. Pharmacologic and nonpharmacologic treatments for urinary incontinence in women: A systematic review and network meta-analysis of clinical outcomes. Ann Intern Med. 2019;170: 465-79.
  • DOI: 10.7326/M18-3227
  • Simpson AN, Garbens A, Dossa F, Coyte PC, Baxter NN, McDermott CD. A costutility analysis of nonsurgical treatments for stress urinary incontinence in women. Female Pelvic Med Reconstr Surg. 2019;25:49-55.
  • DOI: 10.1097/SPV.0000000000000502
  • Richardson K, Fox C, Maidment I, Steel N, Loke YK, Arthur A, et al. Anticholinergic drugs and risk of dementia: case-control study. BMJ. 2018;361k1315.
  • DOI: 10.1136/bmjk1315
  • Kelleher C, Hakimi Z, Zur R, Siddiqui E, Maman K, Aballea S, et al. Efficacy and tolerability of Mirabegron compared with Antimuscarinic monotherapy or combination therapies for overactive bladder: A systematic review and network meta-analysis. Eur Urol. 2018;74:324-33.
  • DOI: 10.1016/j.eururo.2018.03.020
  • Chen H-L, Chen T-C, Chang H-M, Juan Y-S, Huang W-H, Pan H- F, et al. Mirabegron is alternative to antimuscarinic agents for overactive bladder without higher risk in hypertension: a systematic review and meta-analysis. World J Urol. 2018;36:1285-97.
  • DOI: 10.1007/s00345-018-2268-9
  • Barnes KL, Dunivan G, Jaramillo-Huff A, Krantz T, Thompson J, Jeppson P. Evaluation of smartphone pelvic floor exercise applications using standardized scoring system. Female Pelvic Med Reconstr Surg. 2019;25:328-35.
  • DOI: 10.1097/SPV.0000000000000563
  • Nekkanti S, Wu JM, Hudson CO, Pandya LK, Dieter AA. A randomized trial comparing continence pessary to a disposable intravaginal device [poise impressa®] for the non-surgical management of stress urinary incontinence. Female Pelvic Med Reconstr Surg. 2019;26:S95-6.
  • Ethan M Balk, Valerie N Rofeberg, Gaelen P Adam, Hannah J Kimmel, Thomas A Trikalinos, Peter C Jeppson. Pharmacologic and Nonpharmacologic Treatments for Urinary Incontinence in Women: A Systematic Review and Network Meta-analysis of Clinical Outcomes. Ann Intern Med. 2019 2;170(7):465-479.
  • DOI: 10.7326/M18-3227
  • Wald A, Bharucha AE, Cosman B C, Whitehead WE. ACG clinical guideline: management of benign anorectal disorders. Am J Gastroenterol. 2014;109:1141-57; (Quiz) 1058.
  • DOI: 10.1038/ajg.2014.190
  • Paquette IM, Varma MG, Kaiser AM, Steele SR, Rafferty JF. The american society of colon and rectal surgeons' clinical practice guideline for the treatment of fecal incontinence. Dis Colon Rectum. 2015;58:623-36.
  • DOI: 10.1097/DCR.0000000000000397
  • Ridgeway BM, Weinstein MM, Tunitsky-Bitton E. American Urogynecologic Society (AUGS) best-practice statement on evaluation of obstructed defecation. Female Pelvic Med Reconstr Surg. 2018;24:383-91.
  • DOI: 10.1097/SPV.0000000000000635
  • American Urogynecologic Society (AUGS) Guidelines and Statements Committee, Carberry CL, Tulikangas PK, Ridgeway BM, Collins SA, Adam RA. American Urogynecologic Society (AUGS) best practice statement: evaluation and counseling of patients with pelvic organ prolapse. Female Pelvic Med Reconstr Surg. 2017;23:281-7.
  • DOI: 10.1097/SPV.0000000000000424
  • Bradley CS, Zimmerman MB, Qi Y, Nygaard IE. Natural history of pelvic organ prolapse in postmenopausal women. Obstet Gynecol. 2007;109:848-54.
  • DOI: 10.1097/01.A0G.0000255977.91296.5d
  • Gilchrist AS, Campbell W Steele H, Brazell H, Foote J, Swift S. Outcomes of observation as therapy for pelvic organ prolapse: a study in the natural history of pelvic organ prolapse. Neurourol Urodyn. 2013;32:383-6.
  • DOI: 10.1002/nau.22298
  • Dumoulin C, Hunter KF, Moore K, Bradley CS, Burgio KL, Hagen S, et al. Conservative management for female urinary incontinence and pelvic organ prolapse review 2013: summary of the 5th international consultation on incontinence. Neurourol Urodyn. 2016;35:15-20.
  • DOI: 10.1002/nau.22677
  • Braekken IH, Majida M, Engh ME, B0 K. Can pelvic floor muscle training reverse pelvic organ prolapse and reduce prolapse symptoms? An assessor-blinded, randomized, controlled trial. Am J Obstet Gynecol. 2010;203:170.e1-7.
  • DOI: 10.1016/j.ajog.2010.02.037
  • American College of Surgeons COVID-19: Recommendations for Management of Elective Surgical Procedures. https://www.facs.org/covid-19/clinical-guidance/elective-surgery Accessed 2 Apr 2020.
  • Stoffel JT, Peterson AC, Sandhu JS, Suskind AM, Wei JT, Lightner DJ. AuA white paper on nonneurogenic chronic urinary retention: consensus definition, treatment algorithm, and outcome end points. J Urol. 2017;198:153-60. 10.1016/j. juro.2017.01.075.
  • DOI: 10.1016/j.juro.2017.01.075
  • Tunitsky-Bitton E, Murphy A, Barber MD, Goldman HB, Vasavada S, Jelovsek JE. Assessment of voiding after sling: a randomized trial of 2 methods of postoperative catheter management after midurethral sling surgery for stress urinary incontinence in women. Am J Obstet Gynecol. 2015;212:597.e1-9.
  • DOI: 10.1016/j.ajog.2014.11.033
  • Meekins AR, Siddiqui NY, Amundsen CL, Kuchibhatla M, Dieter AA. Improving postoperative efficiency: an algorithm for expedited void trials after urogynecologic surgery. South Med J. 2017;110:785-90.
  • DOI: 10.14423/SMJ.0000000000000733
  • Willis-Gray MG, Wu JM, Field C, Pulliam S, Husk KE, Brueseke TJ, et al. Is a postvoid residual necessary? A randomized trial of two postoperative voiding protocols. Female Pelvic Med Reconstr Surg. 2019.
  • DOI: 10.1097/SPV.0000000000000743
  • Alas A, Hidalgo R, Espaillat L, Devakumar H, Davila GW, Hurtado E. Does spinal anesthesia lead to postoperative urinary retention in same-day urogynecology surgery? A retrospective review. Int Urogynecol J. 2019;30:1283-9.
  • DOI: 10.1007/s00192-019-03893-1
  • Hakvoort RA, Nieuwkerk PT, Burger MP, Emanuel MH, Roovers JP. Patient preferences for clean intermittent catheterization and transurethral indwelling catheterization for treatment of abnormal post-void residual bladder volume after vaginal prolapse surgery. BJOG. 2011;118:1324-8.
  • DOI: 10.1111/j.1471-0528.2011.03056.x
  • Kessler TM, Ryu G, Burkhard FC. Clean intermittent self-catheterization: a burden for the patient? Neurourol Urodyn. 2009;28: 18-21.
  • DOI: 10.1002/nau.20610
  • Hentzen C, Haddad R, Ismael SS, Peyronnet B, Game X, Denys P, et al. Intermittent self-catheterization in older adults: predictors of success for technique learning. Int Neurourol J. 2018;22:65-71.
  • DOI: 10.5213/inj.1835008.504
  • Hentzen C, Haddad R, Ismael SS, Peyronnet B, Game X, Denys P, et al. Predictive factors of adherence to urinary self-catheterization in older adults. Neurourol Urodyn. 2019;38:770-8.
  • DOI: 10.1002/nau.23915
  • Burgio KL. Behavioral treatment of urinary incontinence, voiding dysfunction, and overactive bladder. Obstet Gynecol Clin N Am. 2009;36:475-91.
  • DOI: 10.1016/j.ogc.2009.08.005
  • Dorflinger A, Monga A. Voiding dysfunction. Curr Opin Obstet Gynecol 2001;13:507-12.
  • DOI: 10.1097/00001703-200110000-00010
  • Society of Gynecologic Surgeons A Guide to Female Clean Intermitent Self Catheterization. https://vimeo.com/261183016. Accessed 4 Apr 2020.
  • Shatkin-Margolis A, Yook E, Hill AM, Crisp CC, Yeung J, Kleeman S, et al. Self-removal of a urinary catheter after Urogynecologic surgery: A randomized controlled trial. Obstet Gynecol. 2019;134:1027-36.
  • DOI: 10.1097/A0G.0000000000003531
  • Lavelle ES, Alam P, Meister M, Florian-Rodriguez M, Elmer- Lyon C, Kowalski J, et al. Antibiotic prophylaxis during catheter-managed postoperative urinary retention after pelvic reconstructive surgery: A randomized controlled trial. Obstet Gynecol. 2019;134:727-35.
  • DOI: 10.1097/A0G.0000000000003462
  • Lusardi G, Lipp A, Shaw C (2013) Antibiotic prophylaxis for short-term catheter bladder drainage in adults. Cochrane Database Syst Rev CD005428.
  • DOI: 10.1002/14651858.CD005428.pub2
  • Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, prevention, and treatment of catheter- associated urinary tract infection in adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:625-63.
  • DOI: 10.1086/650482
  • Buckley BS, Lapitan MCM (2010) Drugs for treatment of urinary retention after surgery in adults. Cochrane Database Syst Rev CD008023.
  • DOI: 10.1002/14651858.CD008023.pub2
  • Ramsey S, Palmer M. The management of female urinary retention. Int Urol Nephrol. 2006;38:533-5.
  • DOI: 10.1007/s11255-005-5790-9
  • Shokrpour M, Shakiba E, Sirous A, Kamali A. Evaluation the efficacy of prophylactic tamsulosin in preventing acute urinary retention and other obstructive urinary symptoms following colporrhaphy surgery. J Family Med Prim Care. 2019;8:722-7.
  • DOI: 10.4103/jfmpc.jfmpc_18_19
  • Weber Lebrun EE, Moawad NS, Rosenberg EI, Morey TE, Davies L, Collins WO, et al. COVID-19 pandemic: staged Management of Surgical Services for gynecology and obstetrics. Am J Obstet Gynecol. 2020; 223(1):85.e1-85.e19.
  • DOI: 10.1016/j.ajog.2020.03.038
  • Society of American Gastrointestinal and Endoscopic Surgeons SAGES and EAES Recommendations Regarding Surgical Response to COVID-19 Crisis. https://www.sages.org/recommendations-surgical-response-covid-19/ Accessed 2 Apr 2020.
  • Chen X, Liu Y, Gong Y, Guo X, Zuo M, Li J, et al. Perioperative Management of Patients Infected with the novel coronavirus: recommendation from the joint task force of the Chinese Society of Anesthesiology and the Chinese Association of Anesthesiologists. Anesthesiology. 2020.
  • DOI: 10.1097/ALN.0000000000003301
  • Bacheller CD, Bernstein JM. Urinary tract infections. Med Clin North Am 1997;81:719-30.
  • DOI: 10.1016/s0025-7125(05)70542-3
Еще
Статья научная
SciUp 2024 © 2024 ©